Yeleswaram K - Search Results

1

Involvement of cytochrome P-450 isozymes in melatonin metabolism and clinical implications.

Yeleswaram K, Vachharajani N, Santone K. Yeleswaram K, et al. J Pineal Res. 1999 Apr;26(3):190-1. doi: 10.1111/j.1600-079x.1999.tb00583.x. J Pineal Res. 1999. PMID: 10231734 No abstract available.

2

Preclinical pharmacokinetics and metabolism of BMS-214778, a novel melatonin receptor agonist.

Vachharajani NN, Yeleswaram K, Boulton DW. Vachharajani NN, et al. Among authors: yeleswaram k. J Pharm Sci. 2003 Apr;92(4):760-72. doi: 10.1002/jps.10348. J Pharm Sci. 2003. PMID: 12661062

3

Pharmacokinetics and oral bioavailability of exogenous melatonin in preclinical animal models and clinical implications.

Yeleswaram K, McLaughlin LG, Knipe JO, Schabdach D. Yeleswaram K, et al. J Pineal Res. 1997 Jan;22(1):45-51. doi: 10.1111/j.1600-079x.1997.tb00302.x. J Pineal Res. 1997. PMID: 9062870

4

In vivo disposition and in vitro metabolism of an anxiolytic compound, BMS-184111, in rats.

Yeleswaram K, Volk KJ, Rourick R, Catt JD, Mattson RJ, McGoff KB, Knipe JO. Yeleswaram K, et al. Res Commun Mol Pathol Pharmacol. 1995 Jul;89(1):27-44. Res Commun Mol Pathol Pharmacol. 1995. PMID: 7582859

5

The chimpanzee (Pan troglodytes) as a pharmacokinetic model for selection of drug candidates: model characterization and application.

Wong H, Grossman SJ, Bai SA, Diamond S, Wright MR, Grace JE Jr, Qian M, He K, Yeleswaram K, Christ DD. Wong H, et al. Among authors: yeleswaram k. Drug Metab Dispos. 2004 Dec;32(12):1359-69. doi: 10.1124/dmd.104.000943. Epub 2004 Aug 27. Drug Metab Dispos. 2004. PMID: 15333515

6

The synthesis and characterization of BMS-204352 (MaxiPost) and related 3-fluorooxindoles as openers of maxi-K potassium channels.

Hewawasam P, Gribkoff VK, Pendri Y, Dworetzky SI, Meanwell NA, Martinez E, Boissard CG, Post-Munson DJ, Trojnacki JT, Yeleswaram K, Pajor LM, Knipe J, Gao Q, Perrone R, Starrett JE Jr. Hewawasam P, et al. Among authors: yeleswaram k. Bioorg Med Chem Lett. 2002 Apr 8;12(7):1023-6. doi: 10.1016/s0960-894x(02)00101-4. Bioorg Med Chem Lett. 2002. PMID: 11909708

7

Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels.

Gribkoff VK, Starrett JE Jr, Dworetzky SI, Hewawasam P, Boissard CG, Cook DA, Frantz SW, Heman K, Hibbard JR, Huston K, Johnson G, Krishnan BS, Kinney GG, Lombardo LA, Meanwell NA, Molinoff PB, Myers RA, Moon SL, Ortiz A, Pajor L, Pieschl RL, Post-Munson DJ, Signor LJ, Srinivas N, Taber MT, Thalody G, Trojnacki JT, Wiener H, Yeleswaram K, Yeola SW. Gribkoff VK, et al. Among authors: yeleswaram k. Nat Med. 2001 Apr;7(4):471-7. doi: 10.1038/86546. Nat Med. 2001. PMID: 11283675

8

Heterocyclic aminopyrrolidine derivatives as melatoninergic agents.

Sun LQ, Chen J, Mattson RJ, Epperson JR, Deskus JA, Li WS, Takaki K, Hodges DB, Iben L, Mahle CD, Ortiz A, Molstad D, Ryan E, Yeleswaram K, Xu C, Luo G. Sun LQ, et al. Among authors: yeleswaram k. Bioorg Med Chem Lett. 2003 Dec 15;13(24):4381-4. doi: 10.1016/j.bmcl.2003.09.030. Bioorg Med Chem Lett. 2003. PMID: 14643330

9

Pharmacokinetics and pharmacodynamics of labetalol in the pregnant sheep.

Yeleswaram K, Rurak DW, Hall C, Wright MR, Axelson JE. Yeleswaram K, et al. J Pharmacol Exp Ther. 1992 Aug;262(2):683-91. J Pharmacol Exp Ther. 1992. PMID: 1501116

10

Transplacental and nonplacental clearances, metabolism and pharmacodynamics of labetalol in the fetal lamb after direct intravenous administration.

Yeleswaram K, Rurak DW, Kwan E, Hall C, Doroudian A, Wright MR, Abbott FS, Axelson JE. Yeleswaram K, et al. J Pharmacol Exp Ther. 1993 Oct;267(1):425-31. J Pharmacol Exp Ther. 1993. PMID: 8229771

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page